4/12
11:05 pm
alim
Alimera Sciences, Inc. (NASDAQ: ALIM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Alimera Sciences, Inc. (NASDAQ: ALIM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
4/4
11:04 pm
alim
Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
4/2
10:26 am
alim
Luckie & Company Acquires Marbury Creative Group [Yahoo! Finance]
Medium
Report
Luckie & Company Acquires Marbury Creative Group [Yahoo! Finance]
3/25
08:05 am
alim
Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Low
Report
Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
3/20
08:11 am
alim
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/20
08:00 am
alim
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/19
08:13 am
alim
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network [Yahoo! Finance]
Low
Report
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network [Yahoo! Finance]
3/19
08:00 am
alim
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
Low
Report
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
3/13
09:36 am
alim
New Strong Sell Stocks for March 13th [Yahoo! Finance]
Low
Report
New Strong Sell Stocks for March 13th [Yahoo! Finance]
3/8
10:14 am
alim
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
02:12 pm
alim
Alimera Sciences Inc (ALIM) Reports Significant Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
Low
Report
Alimera Sciences Inc (ALIM) Reports Significant Revenue Growth in Q4 and Full Year 2023 [Yahoo! Finance]
3/7
10:50 am
alim
Alimera Sciences (ALIM) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
Alimera Sciences (ALIM) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/7
07:36 am
alim
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
Low
Report
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
3/7
07:30 am
alim
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
Low
Report
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
3/6
06:14 am
alim
Alimera Sciences, Inc. (NASDAQ:ALIM) Has Found A Path To Profitability [Yahoo! Finance]
Low
Report
Alimera Sciences, Inc. (NASDAQ:ALIM) Has Found A Path To Profitability [Yahoo! Finance]
2/29
08:14 am
alim
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update [Yahoo! Finance]
Medium
Report
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update [Yahoo! Finance]
2/29
08:00 am
alim
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update
Medium
Report
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update
2/21
09:05 am
alim
EyePoint Is Betting The Bank On EYP-1901 [Seeking Alpha]
Low
Report
EyePoint Is Betting The Bank On EYP-1901 [Seeking Alpha]
2/8
08:18 am
alim
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN® [Yahoo! Finance]
Low
Report
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN® [Yahoo! Finance]
2/8
08:00 am
alim
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®
Low
Report
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®
1/25
07:41 am
alim
Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago [Yahoo! Finance]
Low
Report
Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago [Yahoo! Finance]
1/23
12:15 am
alim
Diabetic Retinopathy Market Poised for Growth Driven by Advanced Management Types and Expanding Regional Demand, Forecast 2024-2030 [Yahoo! Finance]
Low
Report
Diabetic Retinopathy Market Poised for Growth Driven by Advanced Management Types and Expanding Regional Demand, Forecast 2024-2030 [Yahoo! Finance]